| 中国肺癌的驱动基因研究进展 |
| |
| 引用本文： | 钱晓燕,石远凯,韩晓红.中国肺癌的驱动基因研究进展[J].科技导报(北京),2014,32(26):42-46. |
| |
| 作者姓名： | 钱晓燕 石远凯 韩晓红 |
| |
| 作者单位： | 中国医学科学院北京协和医学院肿瘤医院肿瘤研究所内科; 抗肿瘤分子靶向药物临床研究北京市重点实验室, 北京 100021 |
| |
| 基金项目： | 国家高技术研究发展计划(863计划)项目(2011AA02A110);国家重大新药创制科技重大专项(2012ZX09303012);国家自然科学基金项目(81372384);北京市自然科学基金项目(7141010);北京市科委重大项目(D141100000214003) |
| |
| 摘 要： | 肺癌是中国发病率及死亡率最高的恶性肿瘤。肿瘤细胞在驱动基因的作用下持续生长，并对该驱动基因的抑制剂具有高敏感性。近年来，针对驱动基因的检测技术不断发展，相应的驱动基因靶向药物也层出不穷。本文主要从中国肺癌的驱动基因、驱动基因的检测及针对驱动基因的靶向治疗3 个方面进行综述，并展望中国肺癌驱动基因的应用前景。
|
| 关 键 词： | 肺癌 驱动基因 靶向治疗 |
Recent Advances in the Study of Driver Genes for Chinese Lung Cancer |
| |
| QIAN Xiaoyan,SHI Yuankai,HAN Xiaohong.Recent Advances in the Study of Driver Genes for Chinese Lung Cancer[J].Science & Technology Review,2014,32(26):42-46. |
| |
| Authors: | QIAN Xiaoyan SHI Yuankai HAN Xiaohong |
| |
| Institution: | Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Cancer Institute&Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China |
| |
| Abstract: | Lung cancer is the leading morbidity and mortality malignant tumor in China. Cancer cells keep growing under the action of driver genes and are sensitive to driver gene inhibitors. Recent years have witnessed continuous developments of driver gene detection technology and driver gene-targeted drugs. This review focus on the driver genes in lung cancer, detection of driver genes and targeted therapy of driver genes, giving a glimpse of the application prospect of driver genes for Chinese patients with lung cancer. |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《科技导报(北京)》浏览原始摘要信息 |
| 点击此处可从《科技导报(北京)》下载免费的PDF全文 |
